Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

Phase 1

4(57.1%)

Phase 2

1(14.3%)

Phase 3

1(14.3%)

N/A

1(14.3%)

7Total

Phase 1(4)

Phase 2(1)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07219212Phase 1Recruiting

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

Role: lead

NCT06311578Phase 1Recruiting

A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

Role: lead

NCT06116786Phase 1Recruiting

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

Role: lead

NCT04892173Phase 3Recruiting

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Role: lead

NCT06667908Phase 2Recruiting

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Role: lead

NCT07525141Phase 1Not Yet Recruiting

A Study of JNJ-1761981 in Participants With Solid Tumors

Role: lead

NCT05231278Not ApplicableCompleted

Confocal Laser Endomicroscopy Nodule Localization by Robotic Bronchoscopy

Role: lead

All 7 trials loaded